To characterize the role of CCL5 on CD8+ T cells tumor infiltration, tumor tissues from CCL5+/+ or CCL5−/− mice after 3 weeks of tumor challenge were examined by immunofluorescence and the number of tumor-infiltrating lymphocytes (TILs) were examined by FACS. The gene discussed is CD8A; the disease is neoplasm.